Cell. 2015 Sep 10;162(6):1338-52.
J Immunol. 2017;199(4):1382-1392.
Nature. 2018;562(7727):423-428.
Proc Natl Acad Sci U S A. 2018;115(16):E3769-E3778.
Proc Natl Acad Sci U S A. 2018;115(26):E6000-E6009.
Cancer Cell. 2019;35(5):767-781.
Proc Natl Acad Sci U S A. 2020;117(7):3693-3703.
J Exp Med. 2020;217(6):e20190730.
Proc Natl Acad Sci U S A. 2020;117(12):6630-6639.
Cell (2014) 156 (4) 744-758
This paper has been highlighted:
a) in the cover of Cell as feature article “Escaping VEGF blockade”,
b) as “Leading Edge Article” by Cell with the commentary: “Galectin-1 Pulls the Strings on VEGFR2” (Pamela Stanley, Cell 2014; 156:625-6),
c) in Nature Medicine (20; 3:250) “Tumors Fight back with a lectin” (M. Bason)
d) in Cancer Discovery (AACR: 2015; doi:10.1158/2159-8290.CD-RW2014-046)
Cancer Cell (2014), 2014 Dec 18. pii: S1535-6108(14)00460-7
This paper has been highlighted:
a) Nature Review Cancer,
b) Cancer Discovery.
Immunity(2012) 37:249-263.
This paper has been highlighted:
a) in Science for the “Editor’s Choice section” (Taming the microglia, Science 2012; 337, 891)
b) as Feature Article Immunity ( Feature Article por Immunity. Galectin-1 for neuroprotection? Nonaka M, Fukuda M. Immunity. 2012 Aug 24;37(2):187-9)
c) by F1000 Faculty of Biology as “Must Read”
Nature Immunology (2009) 10: 981–991.
This study has been ranked in the Top 10 of Nature Immunology (August 2009) and selected by The 1000 Faculty Biology as “Exceptional”.
Nature Immunology (2007) 8:825 – 834
This paper was highlighted as a ‘feature article’ in Nature (July 2007) and Nature Reviews Immunology (July 2007), selected by the Faculty of 1000 Biology as “Must Read” and ranked as the most read paper (1st place) of Nature Immunology (September 2007).
Cancer Cell (2004) 5: 241-251.
This paper has been selected by Cancer Cell for its March 2004 issue cover and highlighted by Nature Rev Cancer (April 2004). These findings have been recently confirmed by other groups in several tumor types including melanoma, pancreatic adenocarcinoma, neuroblastoma and lung carcinoma (for a detailed description of these tumor types please see our recent review (Rabinovich and Croci, Immunity 2012; 36:322-35; cover).
Journal of Experimental Medicine (2012) 209:1985-2000.
This study has been highlighted in the cover of J Exp Med (August issue)
Nature Medicine (2007) 13:1450-1457 (*equal contribution).
This paper was highlighted by Nature (December 2007) and Nature Reviews Immunology (January 2008). The clinical relevance of these findings has also been demonstrated in human pregnancy (Ramhorst et al., Glycobiology 2012; 22:1374-86).
Proceedings of the National Academy of Science USA (2007) 104: 13134-13139.
Cancer Research (2013) 73:86-96
This study has been highlighted by a Commentary in “Nature Reviews Urology” and has been selected as the cover of the January Issue of the journal.
Journal of Experimental Medicine (1999) 190:385-398.
This paper has been highlighted by a News & Views article in Nature (August 1999).The findings reported in this study have been verified in different models of autoimmune inflammation as summarized (Rabinovich and Toscano, Nature Reviews Immunology 2009; 9:338-52).
Journal of Immunology (2007) 178: 436-445
Journal of Immunology (2006) 176: 6323-6332.
Cancer Research2013, 73: 1107–1117 (*equal contribution).
J Immunol. 2015 Apr 1;194(7):3452-62.
Glycobiology. 2014;24(12):1235-6.
Glycobiology. 2014;24(10):885.
Methods Mol Biol. 2015;1207:293-304.
Methods Mol Biol. 2015;1207:249-68.
Immunity. 2016;44(6):1248-50.
Trends Biochem Sci. 2017;42(4):255-273.
Curr Opin Immunol. 2017;45:8-15
Handb Exp Pharmacol. 2018;249:31-61.
Trends Mol Med. 2018;24(4):348-363.
Cancer Cell. 2018;33(2):155-157.
Clin Cancer Res. 2020 Online ahead of print.
J Exp Med. 2020;217(2):e20182041.
Annual Reviews Immunology (2007) 25: 267-96
Immunity(2012)36: 322-335.
Selected for the Cover of March 2004 issue of Immunity.
Selected in the Top 10 Articles of Immunity in 2012.
Nature Reviews Immunology (2009) 9:338-352
Nature Reviews Cancer (2005) 5:29-41.
Nature Immunology (2008) 9:593-601.
Cell Death Differ. 2014 Jun;21(6):941-55 (*equal contribution).
Selected as feature article.
Glycobiology- In press- 2014 (*equal contribution).
American Journal of Pathology2013, 182:29-40.
Leukemia2013, 27: 1413-1416 (*equal contribution).
American Journal of Reproductive Immunology 2013, 69:369-382
Immunology & Cell Biology2013, 91: 159-166
Cell Death & Disease(2013) 4: e462 (*equal contribution).
Cell Death & Differentiation (2013) 20:976-986
Oncoimmunology (2013) 2:e23565.
Blood(2013) 121:3431-3433.
Hepatology (2013) 58:192-204
Current Opinion Hematology (2013) 20:327-335.
Oncoimmunology(2013) 2(5):e24077
European Journal of Immunology (2013) 43:1806-1817 (*equal contribution).
Glycobiology (2012) 22:1374-1386.
FASEB Journal (2012) 26:2788-2798
Frontiers in Bioscience (2012)S4:864-887.
International Journal of Cancer (2012) 131:1131-1141.
Annals New York Academy of Science (2012) 1253:1-15.
Cancer Immunology & Immunotherapy (2012) 61:469-480.
Steroids (2012) 77:67-76
Journal of Leukocyte Biology (2012) 91:321-331
Parasite Immunology (2012) 34:383-387.
Endocrinology (2012)53:2486-2493.
Cell Death & Differentiation (2011) 18:1746-1756.
Hepatology (2011) 53:2097-2106.
Biochemistry (2011) 50:7842-7857
Molecular Immunology(2011) 48: 1940-1949.
Blood (2011) 117:4315-22.
Highlight “Inside Blood” Section.
Plos ONE (2011) 6:e17283.
Journal of Chemical Information and Modeling, (2011) 51:1918-1930. Selected as cover of the issue.
Methods Molecular Biology (2011) 677:355-374.
Current Opinion in Hematology (2011) 18:443-451.
Blood (2011) 117:6638-6649.
FASEB Journal (2011) 25:242-254.
FASEB Journal (2011) 25:242-254.
Journal of Clinical Immunology(2011) 31:10-21.
Histology and Histopathology(2011) 26: 747-759.
International Immunopharmacology (2011) 11:831-838.
Immunobiology (2011) 216:1322-1330
Cell Death and Disease (2011) 26;2:e163.
IUBMB Life (2011) 63:521-527
International Immunopharmacology (2011) 11:1457-1463.
Journal of Biological Chemistry (2010) 285: 9569-9582.
Clinical Cancer Research (2010) 16:2122-2130.
Nature Medicine (2010) 16: 1076–1077.
Journal of Immunology(2010) 185: 4485-4495.
Biochemistry (2010) 49:7652-7658.
IUBMB Life(2010) 62:1-13.
Annals NY Academy of Science (2010) 1183: 158-182.
Special supplement The Immunology of the Year 2009.
Journal of Circadian Rhythms (2010) 19: 8:4
Methods in Enzymology (2010) 480:199-232.
Arthritis & Rheumatism(2009) 60:1604-1614
EMBO Reports (2009) 10: 908–915
Immunological Reviews(2009) 230: 144-159.
Cell Death and Differentiation (2009)16:1093-107
Biochemistry (2009) 48:786-791.
Anticancer Research (2009)29:403-410.
International Journal of Immunopathology & Pharmacology (2009) 22:207-217.
FASEB Journal (2008) 22:1113-1123 (* equal contribution).
Highlighted by the 1000 Faculty Biology.
Expert Opinion Biological Therapies.2008 8:45-57.
FASEB Journal (2008) 22:1032-1042 .
Expert Reviews Molecular Medicine (2008)13;10:e17
Journal of Immunology (2008) 180:4606-4614.
Retrovirology(2008) 5:19doi:10.1186/1742-4690-5-19
Clinical Cancer Research (2008) 14: 3338-3344.
Journal of Cell Biochemistry (2008)105: 381-390.
American Journal of Pathology (2007) 170:546-556.
Cancer Immunology & Immunotherapy(2007) 56:491-499.
Current Opinion Structural Biology (2007) 17:513-520
Glycobiology (2007)17:541-552
Cytokines and Growth Factors Rev (2007) 18: 57-71.
Cellular & Molecular Life Sciences (2007) 64:1670-700.
Scandinavian Journal of Immunology (2007) 6:6143-158
Oncology Reports (2007) 18:483-488.
Cancer Immunoloogy and Immunotherapy(2007) 56:237-248.
Glycobiology (2006) 16: 210-220
Nitric oxide (2006) 14: 30-38
Investigative Ophthalmology & Visual Sciences (2006) 47:1550-1556.
Highlighted in “Inside IOVS section”.
Autoimmunity Rev (2006) 5:349-356.
Journal of Biological Chemistry (2005) 280: 6969-6985 (*equal contribution).
Investigative Ophthalmology & Visual Science (2005) 46: 2056-2063.
Annals Rheumatic Diseases (2005) 64: 96-103
International Journal of Immunopathology & Pharmacology (2005) 18:615-623.
Glycobiology (2005) 15: 519-527.
British Journal of Cancer (2005) 92:1188-1192.
Parasite Immunology (2005) 27:103-114.
Journal of Immunology (2004) 172: 493-502.
Glycoconjugate Journal(2004) 19:565-573
Journal of Immunology (2004) 173 5583-5590
Clinical Immunology (2004) 110: 71-80
Tissue Antigens (2004) 64:1-12.
Molecular & Cellular Biochemistry (2004) 267: 177-185.
Gastroenterology (2003) 124:1381-1394.
Biology of Reproduction (2003) 68:51-59.
Journal of Leukocyte Biology (2003) 73:815-822.
Psychoneuroendocrinology (2003) 28: 687-701.
Glycobiology (2003) 13:119-128.
Cell Death & Differentiation (2002) 9:661-670.
Trends in Immunology (2002) 23: 313-320.
Cancer Immunology and Immunotherapy (2002) 50: 587-603.
Journal of Leukocyte Biology (2002) 71: 741-75
Biochemical et Biophysical Acta (2002) 1572: 273-283.
Journal of Clinical Immunology (2002) 22: 353-3
Clinical and Experimental Immunology (2001) 124: 9-21.
Journal of Rheumatology (2001) 28:1914-1922.
Journal of Leukocyte Biology (2001) 70:70-73
Infection and Immunity, (2001) 69:6589-6598.
European Journal of Immunology (2000) 30: 1331-1339.
Cell Death & Differentiation (2000) 7: 747-753.
Immunology (1999) 97:100-106.
Investigative Ophtalmology & Visual Science (1999) 40: 2971-2977.
Cell Death & Differentiation (1999) 6:711-721.
European Journal of Immunology (1999) 29:563-570.
Journal of Immunology (1998) 160: 4831-4840.
Glycobiology(1998) 8, 59-65.
European Journal of Biochemistry (1998) 252: 400-407.
Journal of Biochemistry (1997) 122: 365-373.
Distinguished with the JB Award (Best paper published in the journal in 1997).
Journal of Leukocyte Biology (1996) 59:363-369.
Nature Immunology (2008) 9:1087-1090.
Glycobiology, (2011) 21: 545–546.
Highlights of the First Keystone Symposium on Glycoimmunology.
Medicina (Buenos Aires) (2011) 71:573-5777.
Editorial Médica Panamericana (1st Ed.) Buenos Aires, Argentina; Madrid, Spain. 60 Chapters (ISBN 950.06-1868-0). April 2004. 680 pages. For advanced students, biologists, biochemists.
Editorial: Paidos (1st Ed.) Buenos Aires, Argentina (Isbn: 9789501201741) Octubre 2014. For students, popular audience and teachers.
In: "Glycobiology" (Ch. 14). C. Sansom and O. Markzman, eds. Scion Publishing Ltd. UK. (2006) 1st. Ed. 450pp. ISBN 1904842275
. In: "Cancer Immunotherapy: Immunosuppression and Tumor Growth". Elizabeth Jaffe & George C. Prendergast, eds. Elsevier; 428pp. 2007- ISBN-13: 978-0-12-372551-8.
In: “Tumor-Induced Immune Suppression. Mechanisms and Therapeutic Reversal” Gabrilovich, Dmitry I & Hurwitz, Arthur, eds. 295pp. Springer, New York.2008-ISBN: 978-0-387-69117-6
In: "Animal Lectins: A Functional View", 1st Ed. (2008). G.R. Vasta & H. Ahmed, eds. CRC Press, Taylor and Francis Publishers. ISBN: 978-0-8493-7269-8.
In: "Animal Lectins: A Functional View", 1st Ed. (2008) G.R. Vasta and H. Ahmed, eds. CRC Press, Taylor and Francis Publishers ISBN: 978-0-8493-7269-8.
. In: “Galectins”. Anatole Klyosov, Zbigniew J, Witczak and David Platt, eds. Publishers: John Wiley & Sons Inc, New Jersey, ACS Series-.288 pp.2008. ISBN: 978-0-470-37318-7
In “Introduction to Human Immunology”. 6th Ed. Fainboim, Geffner, eds. Editorial Médica Panamericana, Buenos Aires. ISBN 978-950-06-0270-9.
In “Introduction to Human Immunology”. 6th. Ed. Fainboim, Geffner, eds. Editorial Médica Panamericana, Buenos Aires. ISBN 978-950-06-0270-9.
In “Clinical Neuroimmunology”.1st. Ed, 2010.Correale, Vila, Garcea, Eds., Editorial Médica Panamericana; Buenos Aires. ISBN 9789500601566
In “Rheumatology: from diagnostic to clinics”. Gustavo Nazwetter, Ed. Editorial Akadia, 2012, In press.
In: "Cancer Immunotherapy: Immunosuppression and Tumor Growth". Elizabeth Jaffe & George C. Prendergast, eds. Elsevier2012, 2nd. Edition; In press.
In: “Tumor-Induced Immune Suppression. Mechanisms and Therapeutic Reversal”
Gabrilovich, Dmitry I.; Hurwitz, Arthur A. (Eds.) 2013, Springer, 2da. Edición
In press
In: “Glycoscience: Biology and Medicine”. DOI 10.1007/978-4-431-54836-2_132-1, Springer Japan 2014. In press